Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia

Dian Zhang Xiong, Yu Ru Yuan, Rong Gao, Qing Wang, Wen Pin Chang

Research output: Contribution to journalArticle

Abstract

Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group) in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4% for control group and 49.6% for observation group. The effective rates were 74.8% for control group and 80.3% for observation group (P

Original languageEnglish (US)
Pages (from-to)146-150
Number of pages5
JournalActivitas Nervosa Superior
Volume55
Issue number4
DOIs
StatePublished - 2013

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Cognitive Neuroscience
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Behavioral Neuroscience

Cite this